World Journal of Hepatology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Lulic I, Lulic D, Pavicic Saric J, Bacak Kocman I, Rogic D. Personalized translational medicine: Investigating YKL-40 as early biomarker for clinical risk stratification in hepatocellular carcinoma recurrence post-liver transplantation. World J Transplant 2025; 15(2): 103036 [PMID: 40535496 DOI: 10.5500/wjt.v15.i2.103036]
URL:	https://www.wjgnet.com/1948-5182/full/v15/i2/103036.htm

(110) (120) (0) (0) (0) (21) (2243) (3)

Number	Citing Articles
1	Jadranka Pavicic Saric, Dinka Lulic, Dunja Rogic, Stipislav Jadrijevic, Danko Mikulic, Tajana Filipec Kanizaj, Nikola Prpic, Laura Karla Bozic, Ivona Adamovic, Iva Bacak Kocman, Zrinka Sarec, Gorjana Erceg, Mirta Adanic, Petra Ozegovic Zuljan, Filip Jadrijevic, Ileana Lulic. YKL-40 in Virus-Associated Liver Disease: A Translational Biomarker Linking Fibrosis, Hepatocarcinogenesis, and Liver Transplantation. International Journal of Molecular Sciences 2025; 26(19) doi: 10.3390/ijms26199584
2	Ileana Lulic, Dinka Lulic, Ivan Durekovic, Jadranka Pavicic Saric, Iva Bacak Kocman, Zrinka Sarec, Dunja Rogic. YKL-40: Revolutionizing cardiac risk prediction and therapy in liver transplantation. World Journal of Transplantation 2025; 15(4): 105621 doi: 10.5500/wjt.v15.i4.105621 Abstract(128) \| Core Tip(125) \| Full Article(HTML)(380) \| Full Article (PDF)-496K(117) \| Full Article with Cover (PDF)-849K(44) \| Full Article (XML)-182K(46) \| Audio-424K(18) \| Peer-Review Report-183K(56) \| Answering Reviewers-117K(57) \| Times Cited (0) \| Total Visits (691) \| Open
3	Zhi-Feng Xu, Yu-Ru Yao, Shen-Yi Ye, Cheng-Fei Zhao. Citrullinated matrisome: An emerging stromal determinant in hepatocellular carcinoma prognostication. World Journal of Gastrointestinal Oncology 2026; 18(9): 117335 doi: 10.4251/wjgo.117335 Abstract(53) \| Core Tip(64) \| Full Article(HTML)(149) \| Full Article (PDF)-1133K(25) \| Full Article with Cover (PDF)-1398K(21) \| Full Article (XML)-106K(22) \| Audio-461K(0) \| Peer-Review Report-230K(23) \| Answering Reviewers-232K(32) \| Times Cited (0) \| Total Visits (290) \| Open
4	Zhongbao Zuo, Chunli Yang, Lanlan Hu, Xiafen Ye, Yazhen Zhang, Lili Huang, Miaochan Wang, Huaizhong Cui, Xiaoqiang Chen, Kenv Pan, Jianfeng Bao, He He, Hamidreza Karimi-Sari. Superior diagnostic efficacy and cost advantage of FibroTouch over CHI3L1 for liver fibrosis in Chinese patients with chronic liver disease. PLOS One 2026; 21(10) doi: 10.1371/journal.pone.0357883

Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.